
Astrana Health Inc
Healthcare · USD
Price
$27.395
Cap
$1.5B
Earnings
1/3 beat
30d Trend
+5%
Upper half of range — momentum is positive
Target range: $26 – $50 (consensus: $35)
Consensus: Strong Buy
Earnings history
Q4 2025
BEAT
0.54 vs 0.26
Q3 2025
MISS
0.01 vs 0.43
Q2 2025
MISS
0.19 vs 0.35
Key macro factors
US Economic Health and Employment: The robust US job market (178,000 jobs added in March, unemployment at 4.3%) could lead to increased enrollment in employer-sponsored health plans, benefiting Astrana Health's service demand, especially as it manages care for various insured patients. [cite: 1, first search result]
Global Economic Instability and Inflation: Ongoing Middle East conflict driving oil prices higher and IMF downgrades to global growth forecasts could lead to broader market volatility and increased operational costs for healthcare providers, potentially impacting Astrana Health's margins despite its value-based care model.
Government Healthcare Policy & Reimbursement Trends: As Astrana Health serves patients covered by Medicare and Medicaid, changes in government reimbursement policies, regulatory changes, and trends in Medicaid disenrollment or Medicare Advantage rates could directly impact the company's revenue and profitability. [cite: 4, first search result]
Astrana Health, Inc., formerly known as Apollo Medical Holdings, Inc., is a physician-centric, technology-powered, risk-bearing healthcare management company headquartered in Alhambra, California, that provides integrated value-based medical care services across the United States. [cite: 4, 10, 4, first search result]
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
